ACIP discussed various proposed changes and revisions to the influenza immunization recommendation, including updating disease incidence and epidemiologic information, editing for clarity, and modifying the recommendation regarding the use of influenza vaccine in children 6 to 23 months of age. Alternative draft language for this section, i.e., "encouraging" versus "recommending" vaccination of this age group was discussed relative to anticipated vaccine uptake and to the implications of each for the Vaccines for Children Program. This section will be reviewed again during the June 2002 ACIP meeting, at which time the committee will determine the final language for the document.

New Advisory Committee on Immunization Practices (ACIP) Makes New Influenza Vaccine Recommendations

• In addition, the committee voted to "encourage when feasible" influenza vaccination for healthy children aged 6 months to 23 months because children in this age group are at substantially increased risk for influenza-related hospitalizations. A recommendation to annually vaccinate healthy children aged 6 months-23 months is expected within the next one to three years. For many years, the committee has recommended vaccination of children 6 months and older who have high-risk medical conditions, such as asthma, diabetes mellitus and heart disease. High-risk children 6 months and older continue to be strongly recommended for annual vaccination.